Translational medicine in China

Science China Life Sciences

Volumn 55, Issue 9, 2012, Pages 834-836

  Zhang, JianMin ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867125470     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-012-4373-0     Document Type: Article

References (26)

1. Marincola F M. Translational medicine: A two-way road. J Transl Med, 2003, 1: 1.
2. Jiang C. Translational medicine in China I: perspectives from Chinese physicians and scientists. Sci China Life Sci, 2011, 54: 1071-1073.
3. Zeng G, Zhong N. Translational medicine: what is in a name from the perspective of Chinese clinicians? Sci China Life Sci, 2011, 54: 1077-1080.
4. Perks B. UK plans 30% funding bump for translational research. Nat Med, 2011, 17: 394.
5. Chen Z, Zhou G. Translational medicine should translate medical science and technology into health care for everyone in China. Sci China Life Sci, 2011, 54: 1074-1076.
6. Liu Q, Zhang X, Zeng Y. Targeted and personalized therapy for cancer: theory and practice in China. Sci China Life Sci, 2011, 54: 1081-1084.
7. Huang P, He Z, Ji S, et al. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature, 2011, 475: 386-389.
8. Pan X, Zhou T, Tai Y H, et al. Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer. Nat Med 2011, 17: 708-714.
9. Cai Y, Shen X, Ding C, et al. Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity, 2011, 35: 596-610.
10. Tang Y, Shu G, Yuan X, et al. FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers. Cell Res, 2011, 21: 316-326.
11. Zhou W J, Geng Z H, Chi S, et al. Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis. Cell Res, 2011, 21: 609-626.
12. Wang W, Liu H, Wang S, et al. A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/beta-catenin signaling and colon cancer cell tumorigenesis. Cell Res, 2011, 21: 730-740.
13. Dong L W, Yang G Z, Pan Y F, et al. The oncoprotein p28GANK establishes a positive feedback loop in beta-catenin signaling. Cell Res, 2011, 21: 1248-1261.
14. Kong Y, Cao W, Xi X, et al. The NKG2D ligand ULBP4 binds to TCRgamma9/delta2 and induces cytotoxicity to tumor cells through both TCRgammadelta and NKG2D. Blood, 2009, 114: 310-317.
15. Hou J, Lin L, Zhou W, et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell, 2011, 19: 232-243.
16. Cao W, Yang Y, Wang Z, et al. Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease. Immunity, 2011, 35: 273-284.
17. Zhao Y, Yang J, Shi J, et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature, 2011, 477: 596-600.
18. Song X, Zhu S, Shi P, et al. IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat Immunol, 2011, 12: 1151-1158.
19. Xu S, Liu X, Bao Y, et al. Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathway. Nat Immunol, 2012, 13: 551-559.
20. Ma F, Xu S, Liu X, et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat Immunol, 2011, 12: 861-869.
21. Liu X, Zhan Z, Li D, et al. Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat Immunol, 2011, 12: 416-424.
22. Xie S, Wang K, Yu W, et al. DIDS blocks a chloride-dependent current that is mediated by the 2B protein of enterovirus 71. Cell Res, 2011, 21: 1271-1275.
23. Littman B H, Di Mario L, Plebani M, et al. What's next in translational medicine? Clin Sci (Lond), 2007, 112: 217-227.
24. Wang X, Wang E, Marincola F M. Translational medicine is developing in China: a new venue for collaboration. J Transl Med, 2011, 9: 3.
25. Marincola F M. The trouble with translational medicine. J Intern Med, 2011, 270: 123-127.
26. Zhang Z, Chen H, Liu D. Translational research: lessons from past research, growing up nowadays, and development goal in future. Sci China Life Sci, 2011, 54: 1085-1088.